Literature DB >> 7535719

Tumor angiogenesis as a prognostic factor in cervical carcinoma.

D L Wiggins1, C O Granai, M M Steinhoff, P Calabresi.   

Abstract

Angiogenesis, the induction of new capillaries and venules, has been associated with tumor growth. Increased tumor size and new vessel growth may further the opportunity for tumor cells to enter the circulation and potentiate metastatic disease. To investigate if tumor angiogenesis could serve as a prognostic factor in cervical carcinoma, we counted microvessels (capillaries and venules) in 29 patients with squamous cell carcinoma of the cervix. Surgical specimens were stained for endothelial cells specifically with Factor VIII to identify all vessels. The microvessels were counted by light microscopy (per 200 x field) in tumor sections with the highest population of microvessels. This was performed by two investigators without knowledge of patient outcome or extent of disease. Microvessel counts in patients with squamous cell carcinoma were significantly different from those of control subjects: 56 +/- 28.9 and 16.3 +/- 3.3 (P = 0.013). There was no correlation between microvessel count and node status, parametrial involvement, depth of invasion, or gross disease. Microvessel count was significantly correlated with vascular space involvement (P = 0.017). Four patients who developed recurrent disease within 1 year had high microvessel counts and yet were node negative and VSI negative at surgery. As shown by Folkman in breast cancer, angiogenesis may also be an independent predictor for recurrent disease in squamous cell carcinoma of the cervix. Microvessel counts could be of prognostic value in patients who do not have other risk factors for disease recurrence.

Entities:  

Mesh:

Year:  1995        PMID: 7535719     DOI: 10.1006/gyno.1995.1062

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  23 in total

1.  The role of the vascular phase in solid tumor growth: a historical review.

Authors:  D Ribatti; A Vacca; F Dammacco
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

Review 2.  Hypoxia and anaemia in patients with cancer of the uterine cervix.

Authors:  Francisco José Andreu-Martínez; Julia M Martínez-Mateu
Journal:  Clin Transl Oncol       Date:  2005-09       Impact factor: 3.405

Review 3.  Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy.

Authors:  S B Fox; A L Harris
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

4.  Cervical carcinoma: standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.

Authors:  H Hawighorst; P G Knapstein; M V Knopp; P Vaupel; G van Kaick
Journal:  MAGMA       Date:  1999-03       Impact factor: 2.310

Review 5.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

6.  Contrast-enhanced ultrasonography of cervical carcinoma: perfusion pattern and relationship with tumour angiogenesis.

Authors:  Wei Zheng; Yong-Hong Xiong; Jing Han; Zhi-Xing Guo; Yu-Hong Li; An-Hua Li; Xiao-Qing Pei
Journal:  Br J Radiol       Date:  2016-06-24       Impact factor: 3.039

7.  Serum vascular endothelial growth factor: a prognostic factor in cervical cancer.

Authors:  Petra L M Zusterzeel; Paul N Span; Marja G K Dijksterhuis; Chris M G Thomas; Fred C G J Sweep; Leon F A G Massuger
Journal:  J Cancer Res Clin Oncol       Date:  2008-07-15       Impact factor: 4.553

8.  Comparison of microvessel density before and after peripheral blood stem cell transplantation in multiple myeloma patients and its clinical implications: multicenter trial.

Authors:  Ho Suk Oh; Jung-Hae Choi; Chan Keum Park; Chul Won Jung; Soon Il Lee; Quehn Park; Cheolwon Suh; Sung-Bae Kim; Hyun Sook Chi; Jae Hoon Lee; Eun Kyung Cho; Soo-Mee Bang; Myung-Ju Ahn
Journal:  Int J Hematol       Date:  2002-12       Impact factor: 2.490

Review 9.  Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer.

Authors:  Jill K Alldredge; Krishnansu S Tewari
Journal:  Oncologist       Date:  2016-03-29

10.  Neoangiogenesis in early cervical cancer: correlation between color Doppler findings and risk factors. A prospective observational study.

Authors:  Matias Jurado; Rosendo Galván; Rafael Martinez-Monge; Jesús Mazaira; Juan Luis Alcazar
Journal:  World J Surg Oncol       Date:  2008-11-25       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.